Lincoln, NE, Sept. 22, 2017 -- NRC Health, the leading provider of patient and consumer insights and healthcare performance-improvement solutions, has launched the healthcare industry’s first holistic metric for measuring consumer loyalty: the NRC Health Loyalty Index. The Loyalty Index enables hospitals and healthcare systems to develop informed marketing strategies, drive patient acquisition, and enhance consumer loyalty.
Hospitals and healthcare systems who rely solely on a single metric to evaluate loyalty, such as patient experience scores, can miss the complete picture. One-dimensional views minimize opportunities to understand a healthcare consumer’s complete journey, including brand awareness and need, or motivation to use their brand over others. The NRC Health Loyalty Index, comprised of seven key attributes of the healthcare journey, provides a 360° view of healthcare consumer loyalty.
The Loyalty Index strengthens strategic healthcare decision-making. It provides marketers a unified way to assess and track brand strengths and weaknesses, benchmark against peers, and identify emerging trends in consumer behavior. With new insight, marketers now have the ability to proactively implement change, prove marketing ROI, and ultimately increase market share.
Brian Wynne, General Manager of Market Insights for NRC Health, said: “The development of the NRC Health Loyalty Index is a meaningful step towards defining and quantifying loyalty in healthcare. We are proud to be at the forefront in helping our partners understand the needs of the communities they serve and transform the way they deliver care.”
The NRC Health Loyalty Index is powered by the NRC Health Market Insights solution. Market Insights provides marketers and strategists with the nation’s largest syndicated healthcare consumer database, capturing insights from 300,000+ consumers annually in more than 300 markets across the U.S.
To learn more about the NRC Health Loyalty Index, stop by booth #601 at SHSMD, September 24-27 in Orlando, FL, and booth #30 at HCIC, October 23-25 in Austin, TX.
About NRC Health
NRC Health (NASDAQ: NRCIA and NRCIB) has helped healthcare organizations illuminate and improve the moments that matter to patients, residents, physicians, nurses, and staff for 35 years. Our empathetic heritage, proprietary methods, and holistic approach enable our partners to better understand the people they care for and, in turn, design experiences that inspire loyalty and trust.
For more information, call 1-800-388-4264, write to [email protected], or visit www.nrchealth.com.
|
|||
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fe7ec2e2-ced5-42dc-8503-6c6b079e652e
Kristine German NRC Health 4024752525 [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



